Children exposed to valproate in utero had a 48% increased risk of developing attention-deficit/hyperactivity disorder (ADHD), compared with children with no exposure to the drug, according to a new study.
Being one of the youngest in a kindergarten class dramatically increases the odds that a child will be diagnosed and treated for attention deficit-hyperactivity disorder (ADHD), a large new U.S. study has concluded.
ORLANDO, Fla.—Rates and routes of prescription stimulant abuse among both adolescents and adults is concerning, suggests a pair of studies presented during a poster session at Psych Congress 2018.
Methylphenidate normalizes amygdala reactivity during fear learning in adolescent males with disruptive behavior disorder (DBD), including those without comorbid ADHD, a new pharmacological MRI study shows.
Should we treat patients who are on Suboxone or methadone with stimulants? Psych Congress cochair Rakesh Jain, MD, MPH, outlines several points to consider.
The prevalence of attention-deficit/hyperactivity disorder (ADHD) diagnoses in the United States increased significantly from 1997 to 2016, reports a new study.
"I am uncertain of how to diagnose ADHD in my adult patients with major depression. Is this diagnosis even warranted in a patient with depression?"
Tim Wilens, MD, talks with Charles Raison, MD, about changes in ADHD diagnostic criteria in DSM-5, including the number of symptoms needed and what relative impairment means when assessing adult ADHD.
Timothy Wilens, MD, and Charles Raison, MD, discuss how clinicians can distinguish bipolar disorder from attention deficit hyperactivity disorder (ADHD) in children. They also explore which therapies might be appropriate.
Charles Raison, MD, comments on a recent Lancet study detailing how five major psychiatric disorders—autism, ADHD, bipolar disorder, major depressive disorder, and schizophrenia—are genetically connected.